No CDSCO panel nod to Dr Reddys for Sputnik V yet, additional data sought Ruchika Sharma2 April 2021 1:01 PM ISTSputnik V has demonstrated an efficacy rate of 91.6 per cent in the interim analysis of phase 3 clinical trial, which included data on 19,866...
CDSCO panel to decide on emergency use of Sputnik V today Ruchika Sharma31 March 2021 3:10 PM ISTNew Delhi: Meeting of Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) will be held on Wednesday to...
Glenmark secures CDSCO panel nod for manufacturing, marketing acne drug Tazarotene Medical Dialogues Team28 March 2021 11:00 AM ISTNew Delhi: After reviewing the proposal for Tazarotene Lotion 0.045%, the Central Drugs Standard Control Organization (CDSCO) committee has given its...
AstraZeneca gets CDSCO panel okay for Clinical Trial Of Asthma drug Budesonide Glycopyrronium Medical Dialogues Team26 March 2021 5:44 PM ISTNew Delhi: The Subject Expert Committee functional under the Central Drugs Standard Control Organization (CDSCO) has given its nod to AstraZeneca to...
Update product insert of 4th generation HIV In-vitro diagnostics kits: CDSCO to all licensees Medical Dialogues Team23 March 2021 5:24 PM ISTNew Delhi: In order to avoid unnecessary delays in evaluation, the Central Drugs Standard Control Organization (CDSCO) has requested all the licensees...
Serum Institute secures CDSCO panel nod for bridge trial of Novavax Covid-19 vaccine Medical Dialogues Team18 March 2021 4:48 PM ISTNew Delhi: In order to tackle the Covid-19 upsurge, the Subject Expert Committee (SEC) committee functional under the Central Drugs Standard Control...
CDSCO Flags 14 Drug Samples including Aspirin, Rosuvastatin As Not Of Standard Quality Ruchika Sharma17 March 2021 6:35 PM ISTNew Delhi: In its recent drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 14 medicine...
Novartis gets CDSCO Committee nod to Xolair to treat rhinosinusitis with nasal polyps Medical Dialogues Team17 March 2021 9:15 AM ISTNew Delhi: Subject Expert Committee (SEC) functional under Central Drugs Standard Control Organization (CDSCO) has granted permission to Novartis...
Include more Govt sites: CDSCO panel to Sanofi on clinical trial of pulmonary disease drug Medical Dialogues Team16 March 2021 9:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Citing voglibose, sitagliptin incompatibility, CDSCO panel rejects Hetero Labs proposal for antidiabetic FDC drug Medical Dialogues Team13 March 2021 6:50 PM ISTNew Delhi: In a setback to Hetero Labs, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...
Sun Pharma secures CDSCO panel nod for Dextromethorphan Hydrobromide, Chlorpheniramine maleate FDC Medical Dialogues Team12 March 2021 6:47 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drugs Standard Control Organization (CDSCO) has given its nod to Sun...
CDSCO Committee recommends Bharat Biotech to drop clinical trial mode label for Covaxin Medical Dialogues Team11 March 2021 2:55 PM ISTNew Delhi: In order to boost the acceptance of indigenously developed Bharat Biotech's Covid-19 vaccine, the Subject Expert Committee (SEC) committee...
